A coalition of 30 nonprofit health organizations promoting the development of drugs, vaccines, and other health-related products designed for use in the developing world is calling on US policy makers and regulators to accelerate scientific innovation and streamline the approval process for safe and affordable new medical products that can be used worldwide.
At a time when a sluggish economy is prompting the US Congress and the Obama administration to consider ways to reduce government spending, a report issued by the Global Health Technologies Coalition, funded by the Bill & Melinda Gates Foundation, makes a case in a policy report why US policy makers should sustain US investment in global health research and development (http://bit.ly/lsbDkG).
Mitka M. Report Calls for US Funding to Speed Global Health Research and Innovation. JAMA. 2011;305(23):2399–2401. doi:10.1001/jama.2011.828